IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Introgen Therapeutics Inc

CUSIP: 46119F107 | 2 institutional holders

Quarters

Q4 2015Q2 2015Q4 2013Q3 2013Q2 2013
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2015

Beck Capital Management, LLC26,000
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Beck Capital Management, LLC
26,000$00.0%MomentumMediumAustin, TX2016-02-12